STRATEGIC ANALYSIS OF THE WORLD PHARMACEUTICAL INDUSTRY Dragan Kesič∗ Received: 28. 2. 2007 Case study Accepted: 9. 7. 2008 UDC 65.01:615 The world pharmaceutical industry has been changing profoundly in the last decade. Intensive globalization‚ increased competitiveness and the fight for global market shares create new challenges for pharmaceutical companies. Fast globalization definitively reinforces the consolidation of the world pharmaceutical industry. Alliancing in forms of mergers and
Premium Pharmaceutical industry Generic drug Marketing
Presentation on: Pfizer and the Pharmaceutical Industry Fletcher Leung Analyst Investment Analysis Group February 15‚ 2002 Presentation Agenda • Industry Overview: Research Based Pharmaceuticals • Pfizer – Company Specifics – Performance – Growth Drivers • Valuation – Comparables Analysis – DCF • Recommendation February 15‚ 2002 Page 2 Investment Analysis Group 1 Industry Overview Economic •Cost Effective Demographic Sociocultural •Aging Population
Premium
Supply and Demand Pharmaceutical Industry In today ’s society‚ a large percentage of the population requires prescription drugs to treat injury or illness. In some cases‚ the need for drugs may be short term and in other cases‚ the drugs may be required for the remainder of an individual ’s life. In all cases‚ prescription drugs are not free; the individual or his or her insurance company pays. The type of drug and available substitutions generally drive the costs. In this paper‚ I will summarize
Premium Pharmacology Pharmaceutical industry Food and Drug Administration
EXECUTIVE SUMMARY Global Pharma Industry is likely to grow at a CAGR of 5% to US $ 1 Trillion by 2013 The Pharmaceuticals Industry in India is the world’s 3 largest in terms of volume and stands 14th in terms of sale. Domestic pharma sector benefitted from increased thrust on Rural Health through bigger budgetary allocations in the Budget of 2009-10 According to PWC in 2010‚ India joined the league of Top 10 global pharmaceutical markets in terms of sales by 2020 with value reaching
Premium Pharmaceutical industry Generic drug
Melina Guzman Mrs. Reed Period: 4 November 7‚ 2011 The Truth about Pharmaceutical Industry “Greed is a bottomless pit which exhausts the person in an endless effort to satisfy the need without ever reaching satisfaction” (Erich). Living in today’s society it’s impossible for you not see advertisement for the Pharmaceutical industry. Whether it’s a billboard‚ a commercial or an elderly person wearing a sponsored rain jacket their advertisements are hard to miss. Every day we see these
Premium Pharmaceutical industry Pharmacology Clinical trial
ETHICAL ISSUES IN THE PHARMACEUTICAL INDUSTRY Ethical Issues in the Pharmaceutical Industry Abstract No one can deny that the pharmaceutical industry has made significant contributions to human progress. The pharmaceutical industry has been responsible for drugs that have saved millions of lives‚ cured many forms of cancer‚ and ensured that an AIDS diagnosis is no longer an automatic death sentence. Yet despite this there are questions that the public has on whether the industry has been fulfilling
Premium Physician Clinical trial Pharmaceutical industry
INTRODUCTION The pharmaceutical industry is praised as one of the leading industrial sectors. The fruits of its extensive research and development are traded worldwide and have improved the length and quality of life of countless individuals. At the same time‚ however‚ the industry is criticized for its marketing and pricing practices—and even for its research and development priorities. Industry’s consistently high profits and large expenditures on research and development as well as on marketing
Premium Cost Supply and demand Economics
for the industry going forward? 1.Though the average level of profitability in the pharmaceutical industry has been declining over time (In 2002‚ the average ROIC in the industry was 21.6%; by 2006‚ it had fallen to 14.5%)‚ historically‚ the pharmaceutical industry has been a profitable one. Because- Name of industry | Average ROIC(Between 2002 and 2006) | Pharmaceuticals | 16.45%(large) | computer hardware | 12.76% | Electronics | 3.88% | 2. The prospect for the industry for going
Premium Pharmaceutical industry Pharmacology Generic drug
| Ethics in Corporate Society | | PHARMACEUTICAL MARKETING-the growing ethical concern? Analytical Report | | | Madiha Raza Noama Naeem Sheikh Zargham Zaigham LETTER OF AUTHORIZATION November 5‚ 2011 Dear Readers‚ As students of BBA‚ our course instructor of Ethics in Corporate Society‚ Ms. Tania Danish authorized us to make a report on the “PHARMACEUTICAL MARKETING-the growing ethical concern?” We were required to make a report in accordance to our learning in the course
Premium Pharmacology Pharmaceutical industry Pharmacy
the previous financial year. Following are the main macro environmental factors from FY08 that had direct bearing on the company’s revenue and profitability figures: GDP Growth Encouraged by the continuing thrust in investments which grew by 31.6%‚ the GDP growth in the third quarter of fiscal 2008 came in at 8.4% compared to 9.1% in the same quarter last year. A good kharif season supported growth of 3.2% in agriculture while Industry and services grew at a moderated level of 8.4% and 10
Premium Inflation Monetary policy